University of Oxford: Oxford spinout MiroBio acquired by Gilead Sciences for $405m
MiroBio, an Oxford biotech spinout focused on therapeutics for inflammatory diseases, is set to be acquired by global biopharmaceutical company Gilead Sciences following the completion of a deal worth approximately £332m (USD$405m).With!-->…